Inactive Instrument
Eurofins Cerep Stock Euronext Paris
Stocks
FR0012045946
Biotechnology & Medical Research
|
End-of-day quote
Euronext Paris
|
||
| - EUR | - |
|
| 04-29 | Eurofins-Cerep SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| 25-10-02 | Eurofins-Cerep SA Reports Earnings Results for the Half Year Ended June 30, 2025 | CI |
| Market Cap | 82.22M 95.24M 77.13M 70.25M 132M 9.11B 134M 904M 354M 4.56B 358M 350M 15.18B | P/E 2024 * |
-
| P/E 2025 | - |
|---|---|---|---|---|---|
| Enterprise Value | 61.18M 70.87M 57.4M 52.28M 98.3M 6.78B 99.66M 673M 264M 3.39B 266M 260M 11.29B | EV / Sales 2024 |
2.02x | EV / Sales 2025 | 1.67x |
| Free-Float |
4.22% | Yield 2024 * |
-
| Yield 2025 | - |
| Manager | Title | Age | Since |
|---|---|---|---|
Damien Vielliard
CEO | Chief Executive Officer | - | 2024-04-10 |
| Director | Title | Age | Since |
|---|---|---|---|
Rodolphe Simonot
BRD | Director/Board Member | - | - |
Paul Ratcliffe
CHM | Chairman | - | 2023-08-10 |
Damien Vielliard
BRD | Director/Board Member | - | 2024-05-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.68% | -2.28% | +2.16% | +19.70% | 48.42B | |
| +4.07% | +2.43% | +483.70% | +623.80% | 43.66B | |
| +4.33% | +0.98% | +12.80% | +88.53% | 39.51B | |
| +1.94% | -0.31% | +26.24% | +12.62% | 38.95B | |
| -0.50% | 0.00% | +20.60% | +60.49% | 32.61B | |
| -0.44% | -3.22% | - | - | 16.32B | |
| +3.22% | -0.88% | +30.42% | +135.47% | 16.15B | |
| -0.62% | -0.06% | +3.46% | +27.74% | 14.16B | |
| +2.35% | +3.48% | +82.95% | +43.41% | 13.37B | |
| Average | +1.67% | +0.02% | +82.79% | +126.47% | 29.24B | |
| Weighted average by Cap. | +1.93% | +0.04% | +101.58% | +151.17% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 40.49M 46.9M 37.98M 34.6M 65.05M 4.48B 65.95M 445M 174M 2.25B 176M 172M 7.47B | 41.1M 47.61M 38.56M 35.12M 66.03M 4.55B 66.95M 452M 177M 2.28B 179M 175M 7.59B |
| Net income | 7.15M 8.29M 6.71M 6.11M 11.5M 792M 11.65M 78.68M 30.83M 397M 31.11M 30.44M 1.32B | 4.78M 5.54M 4.49M 4.09M 7.68M 530M 7.79M 52.6M 20.61M 265M 20.8M 20.35M 883M |
| Net Debt | -17.25M -19.98M -16.19M -14.74M -27.72M -1.91B -28.1M -190M -74.35M -957M -75.03M -73.41M -3.18B | -21.03M -24.37M -19.73M -17.97M -33.8M -2.33B -34.27M -231M -90.65M -1.17B -91.48M -89.5M -3.88B |
Employees
-
Select your edition
All financial news and data tailored to specific country editions
